Dr. Adriana E. Palade, MD

Dr. Palade practices at Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky.

Dr. Palade's NPI, 1083705859, was assigned on September 27, 2006. Dr. Palade holds Kentucky license 48306.

Dr. Palade's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD, at 200 Abraham Flexner Way, Louisville, KY 40202.

Dr. Palade's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky. Dr. Palade is also affiliated with UofL Health - Jewish Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Palade to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Palade practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Palade's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Palade's licenses on file in 2 states: Kentucky and West Virginia.

CMS data shows 202 Medicare services from Dr. Palade across 3 procedure codes in 2024, for 174 Medicare patients. Medicare paid $22,801 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Palade in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Palade's median patient age at 68, with 61% women.

In 2024, Dr. Palade wrote 514 Medicare Part D claims for 86 patients. 79% of them were for generic drugs. CMS names the drug for 414 of them, across 16 drugs with 11 or more claims each, at $130,933 in total drug cost. In 2023, CMS named 1,354 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Palade for performance year 2024, reported as part of a group. Dr. Palade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Palade, published from 2018 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Electroencephalography and Seizures. Dr. Palade's most frequent co-authors are Nicholas M. Barbaro, MD, Riwaj Bhagat, MD and Edward F. Chang, MD.

CMS Open Payments shows 65 general payments to Dr. Palade from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. SK Life Science, Inc. paid the most, $6,582.